To investigate if the association of reduced LVEF and elevated cMLC-1 that we previously noted in mice was clinically relevant in humans, archived plasma samples obtained from breast cancer patients (n=5) administered anthracyclines followed by taxanes and trastuzumab were analyzed for cMLC-1. The gene discussed is MYL3; the disease is breast carcinoma.